{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:48:26Z","timestamp":1782978506589,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clim.2021.108802","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:23:59Z","timestamp":1626877439000},"page":"108802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Altered NK-cell compartment and dysfunctional NKG2D\/NKG2D-ligand axis in patients with ataxia-telangiectasia"],"prefix":"10.1016","volume":"230","author":[{"given":"Maria Giovanna","family":"Desimio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Finocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigliola","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Di Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Giancotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Piane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Montin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dellepiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cancrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.clim.2021.108802_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.clim.2021.108802_bb0015","first-page":"4255","article-title":"ATM and ATR signaling at a glance","volume":"128","author":"Awasthi","year":"2015","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/dvdy.24522","article-title":"Neurodegeneration in ataxia-telangiectasia: multiple roles of ATM kinase in cellular homeostasis","volume":"247","author":"Choy","year":"2018","journal-title":"Dev. Dyn."},{"issue":"2","key":"10.1016\/j.clim.2021.108802_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.clim.2021.108802_bb0030","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1128\/JVI.00917-12","article-title":"Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection","volume":"86","author":"Kulinski","year":"2012","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.clim.2021.108802_bb0035","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2011-08-373639","article-title":"Mitochondrial dysfunction in ataxia-telangiectasia","volume":"119","author":"Valentin-Vega","year":"2012","journal-title":"Blood."},{"issue":"16","key":"10.1016\/j.clim.2021.108802_bb0040","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/ddh189","article-title":"Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice","volume":"13","author":"Schubert","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.clim.2021.108802_bb0045","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1182\/blood-2002-03-0976","article-title":"Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia","volume":"100","author":"Giovannetti","year":"2002","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.clim.2021.108802_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.01.053","article-title":"Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity","volume":"131","author":"Driessen","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","article-title":"Ataxia-telangiectasia: immunodeficiency and survival","volume":"178","author":"van Os","year":"2017","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12887-018-1156-1","article-title":"Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia","volume":"18","author":"Krauthammer","year":"2018","journal-title":"BMC Pediatr."},{"issue":"4","key":"10.1016\/j.clim.2021.108802_bb0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.clim.2021.108802_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ppul.22817","article-title":"Infections of the respiratory system in patients with ataxia-telangiectasia","volume":"49","author":"Schroeder","year":"2014","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2011.03.007","article-title":"Premature ageing of the immune system underlies immunodeficiency in ataxia telangiectasia","volume":"140","author":"Exley","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2013.00508","article-title":"The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in Normal, infected, and Cancer cells","volume":"4","author":"Cerboni","year":"2014","journal-title":"Front. Immunol."},{"issue":"5428","key":"10.1016\/j.clim.2021.108802_bb0090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.clim.2021.108802_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/85321","article-title":"Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells","volume":"2","author":"Groh","year":"2001","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2021.108802_bb0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/ijms18081677","article-title":"Regulation of NKG2D-dependent NK cell functions: the yin and the Yang of receptor endocytosis","volume":"18","author":"Molfetta","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.clim.2021.108802_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/sji.12072","article-title":"Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications","volume":"78","author":"Chitadze","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0110","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28497","article-title":"Secretory pathways generating immunosuppressive NKG2D ligands: new targets for therapeutic intervention","volume":"3","author":"Baragano Raneros","year":"2014","journal-title":"Oncoimmunology."},{"issue":"6","key":"10.1016\/j.clim.2021.108802_bb0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.clim.2021.108802_bb0120","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3389\/fimmu.2018.02040","article-title":"NKG2D ligands-critical targets for Cancer immune escape and therapy","volume":"9","author":"Schmiedel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0125","first-page":"8","article-title":"NKG2D ligands as therapeutic targets","volume":"13","author":"Spear","year":"2013","journal-title":"Cancer Immun."},{"key":"10.1016\/j.clim.2021.108802_bb0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fimmu.2019.00661","article-title":"NKG2D\/NKG2-ligand pathway offers new opportunities in cancer treatment","volume":"10","author":"Frazao","year":"2019","journal-title":"Front. Immunol."},{"issue":"6142","key":"10.1016\/j.clim.2021.108802_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0140","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.clim.2021.108802_bb0145","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/s41418-018-0272-7","article-title":"GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells","volume":"26","author":"Pintado-Berninches","year":"2019","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.clim.2021.108802_bb0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molcel.2004.10.029","article-title":"Mar\u00eda-Jos\u00e9 Recio, et al. a pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci","volume":"16","author":"Riballo","year":"2004","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.clim.2021.108802_bb0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.onc.1204111","article-title":"Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid","volume":"20","author":"Gatei","year":"2001","journal-title":"Oncogene."},{"issue":"32","key":"10.1016\/j.clim.2021.108802_bb0160","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1523\/JNEUROSCI.0774-19.2019","article-title":"Accumulation of cytoplasmic DNA due to ATM deficiency activates the microglial viral response system with neurotoxic consequences","volume":"39","author":"Song","year":"2019","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/imr.12600","article-title":"Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells","volume":"280","author":"Raulet","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-016-0341-y","article-title":"Large deletion of MAGT1 gene in a patient with classic kaposi sarcoma, CD4 lymphopenia, and EBV infection","volume":"37","author":"Brigida","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.5MA0220-239R","article-title":"Partial T cell defects and expanded CD56(bright) NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene","author":"Cifaldi","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.clim.2021.108802_bb0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.virol.2010.11.018","article-title":"The HIV-1 Nef protein has a dual role in T cell receptor signaling in infected CD4+ T lymphocytes","volume":"410","author":"Neri","year":"2011","journal-title":"Virology."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40760-x","article-title":"Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency","volume":"9","author":"Giuliani","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.clim.2021.108802_bb0190","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1096\/fj.12-223057","article-title":"Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells","volume":"27","author":"Matusali","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2021.108802_bb0195","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0200","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3389\/fimmu.2019.02078","article-title":"Human NK cell development: one road or many?","volume":"10","author":"Cichocki","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2016.00351","article-title":"Features of memory-like and PD-1(+) human NK cell subsets","volume":"7","author":"Della Chiesa","year":"2016","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2021.108802_bb0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 negative NK cells: origin, function, and role in chronic viral disease","volume":"31","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Trends Immunol."},{"issue":"6908","key":"10.1016\/j.clim.2021.108802_bb0215","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature."},{"issue":"12","key":"10.1016\/j.clim.2021.108802_bb0220","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4049\/jimmunol.171.12.6891","article-title":"Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma","volume":"171","author":"Doubrovina","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108802_bb0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jocn.2009.05.023","article-title":"The soluble major histocompatibility complex class I-related chain a protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma","volume":"17","author":"Ma","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.clim.2021.108802_bb0230","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.1200796","article-title":"Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses","volume":"189","author":"Hilpert","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108802_bb0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41375-019-0618-2","article-title":"ATM activity in T cells is critical for immune surveillance of lymphoma in vivo","volume":"34","author":"Riabinska","year":"2020","journal-title":"Leukemia."},{"issue":"8","key":"10.1016\/j.clim.2021.108802_bb0240","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56-\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.clim.2021.108802_bb0245","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.4049\/jimmunol.0901437","article-title":"Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment","volume":"183","author":"Gonzalez","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus","volume":"208","author":"Bj\u00f6rkstr\u00f6m","year":"2011","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.clim.2021.108802_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005645","article-title":"Different features of V\u03b42 T and NK cells in fatal and non-fatal human Ebola infections","volume":"11","author":"Cimini","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1\u20132","key":"10.1016\/j.clim.2021.108802_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2006.05.028","article-title":"Persistence of CD16+\/CD56-\/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis","volume":"179","author":"Nguyen","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108802_bb0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10067-003-0814-2","article-title":"Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma","volume":"23","author":"Antonioli","year":"2004","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.clim.2021.108802_bb0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00011-018-1142-y","article-title":"Inflammation, a significant player of Ataxia-telangiectasia pathogenesis?","volume":"67","author":"Zaki-Dizaji","year":"2018","journal-title":"Inflamm. Res."},{"issue":"6","key":"10.1016\/j.clim.2021.108802_bb0275","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00262-009-0807-3","article-title":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked","volume":"59","author":"von Lilienfeld-Toal","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2010.05.014","article-title":"MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction","volume":"406","author":"Nolting","year":"2010","journal-title":"Virology."},{"issue":"9","key":"10.1016\/j.clim.2021.108802_bb0285","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni1239","article-title":"Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance","volume":"6","author":"Oppenheim","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cellimm.2006.03.002","article-title":"Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression","volume":"239","author":"Song","year":"2006","journal-title":"Cell. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108802_bb0295","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-05-2520","article-title":"Proteolytic release of soluble UL16-binding protein 2 from tumor cells","volume":"66","author":"Waldhauer","year":"2006","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.clim.2021.108802_bb0300","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/eji.201444512","article-title":"C-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells","volume":"44","author":"Molfetta","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108802_bb0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1074-7613(02)00505-8","article-title":"Impairment of NK cell function by NKG2D modulation in NOD mice","volume":"18","author":"Ogasawara","year":"2003","journal-title":"Immunity."},{"issue":"2","key":"10.1016\/j.clim.2021.108802_bb0310","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4049\/jimmunol.175.2.720","article-title":"Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo","volume":"175","author":"Wiemann","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2021.108802_bb0315","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/0008-5472.CAN-06-3452","article-title":"Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.clim.2021.108802_bb0320","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.bbagen.2014.03.007","article-title":"Matrix metalloproteinases in inflammation","volume":"1840","author":"Nissinen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2021.108802_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002922","article-title":"An NKG2D-mediated lymphoid stress surveillance response with high interindividual variation","volume":"3","author":"Shafi","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.clim.2021.108802_bb0330","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.4049\/jimmunol.181.9.6170","article-title":"Barreira da Silva R, Raine CS, et al. human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition","volume":"181","author":"L\u00fcnemann","year":"2008","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.clim.2021.108802_bb0335","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1158\/1078-0432.CCR-15-0845","article-title":"Nonblocking monoclonal antibody targeting soluble MIC revamps endogenous innate and adaptive antitumor responses and eliminates primary and metastatic tumors","volume":"21","author":"Lu","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"6383","key":"10.1016\/j.clim.2021.108802_bb0340","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science."},{"issue":"11","key":"10.1016\/j.clim.2021.108802_bb0345","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1002\/eji.201040568","article-title":"IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA","volume":"40","author":"Kloess","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2021.108802_bb0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2017.08.010","article-title":"The potential and promise of IL-15 in immuno-oncogenic therapies","volume":"190","author":"TO","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2021.108802_bb0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the IL-15\/IL-15R\u03b1 complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162100139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162100139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:05:04Z","timestamp":1761494704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162100139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":71,"alternative-id":["S152166162100139X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108802","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered NK-cell compartment and dysfunctional NKG2D\/NKG2D-ligand axis in patients with ataxia-telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108802"}}